about
MAP kinase pathways in the yeast Saccharomyces cerevisiaeDiscovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesisIdentification of positive regulators of the yeast fps1 glycerol channelDiscovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitorsIn vitro activity of A-192411.29, a novel antifungal lipopeptideEfficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed miceUtility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide clAntifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.Antifungal peptides: novel therapeutic compounds against emerging pathogensAspergillus fumigatus and aspergillosisParadoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.Properties of various Rho1 mutant alleles of Cryptococcus neoformans.Peptide-based Antifungal Therapies against Emerging Infections.Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma samplingCompartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus.Treatment options in Invasive Aspergillosis.In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.Topological and mutational analysis of Saccharomyces cerevisiae Fks1Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.Resistance to echinocandin-class antifungal drugs.Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.Timely Endocytosis of Cytokinetic Enzymes Prevents Premature Spindle Breakage during Mitotic Exit.Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factorCurrent perspectives on echinocandin class drugs.Antifungal research strategies aiming for new targets.Review of the pharmacology and clinical studies of micafunginGageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungiComparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolatesEfg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
P2860
Q24548569-010AD3E7-E906-4151-9A4E-3BA65A4ADE55Q24645700-7E3BE8C6-FB99-4240-8BD2-8DBBA11F2C47Q27935908-1BB62DD3-DDBB-4B07-B68F-E04DDA7C8702Q28343863-46D64024-513E-489F-B82A-69C87F09D3C8Q28344147-826926F1-CE71-449E-A68B-12E8CD02C052Q28344589-11619D7E-B025-46BA-B6F6-5341CA196ABBQ28367823-4186A624-0711-42CD-80FB-38E6F9E35DF9Q28369150-2000A9D4-977E-4A17-A671-CC1C8B6443B6Q28369443-E2784045-0FC3-4941-BDB0-A5AD598BB3F9Q29617908-1D11E960-27B8-4398-B07F-C7BFD5203F1FQ30570494-F0548996-E1D2-419C-BA3A-23276FB54F26Q30837205-6FAD5226-0493-4247-A1A6-3909F1DA7E82Q33749111-8FA0A12E-90E1-4748-A70C-2227EBADB371Q33791723-4E9C79E6-1E31-4D1E-BEAA-EF4E137C5A20Q33862289-AA2CFE8E-FE14-4E78-A3A7-4C1CE9EDB5D3Q33977578-8077B043-DCA9-4001-9C2D-4F61AB1E4581Q33981387-B7A5A8E7-11A9-476D-A296-F9F6BEBC499CQ33981480-CEDA05A2-A1DB-4E0A-8F3E-87CAFD6F4990Q33982369-B7B6BC95-7E71-4E65-B518-3670ABA75A6AQ33983159-EF79291A-3F1A-45CF-8970-674D1C3E3FF0Q33983506-85D1100C-47D3-4B85-BC7D-5C06805D9CB4Q34104748-407DE423-D3D1-49BC-9B1F-63112E17392AQ34231728-9B3A5D41-4A3B-42FA-BE24-721D2B867665Q34357504-22C8AA17-76AB-4590-9B4B-58EBA02DCBE9Q34881309-BD12AD7E-5CD7-4B78-A379-2F338C052915Q35138937-30ECA667-FE6C-4CC1-AAE5-06687E5B8511Q35697550-39FA4496-E464-48CF-9F29-D2754182C447Q36156130-78F22721-DE85-49D2-8B60-7CF4E07606D2Q36482736-77EF9852-F17E-478A-815F-F37EB3BE0235Q36849595-604B0479-14C1-446C-AB9C-84815224CADDQ36949545-9E25F5D4-A8D0-4251-B39F-E077B36AC709Q37119342-31F9978F-A1AE-43DD-B4B9-CCA28126DE59Q37544379-B35487CB-2F13-4983-8745-F9BD31AE09E1Q37554055-9ED05C20-C670-4E62-82E1-0574782C1D4BQ37588637-BC896D8D-49BA-492A-BCA5-D8608B128074Q37669740-08FE5142-B557-4423-914B-6BBCDA1D2830Q39027556-943C0258-9863-4C87-99D1-3403F1514D06Q39556728-4E3132D2-C6E7-4DA3-9A5D-CD89EEB4CBCCQ39652840-38B8E8F6-4E7D-405F-94BA-40C5D6D17291Q39658147-8A6AD55C-4F6D-4DAE-B16E-476B6EC410A0
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Lipopeptide inhibitors of fungal glucan synthase.
@ast
Lipopeptide inhibitors of fungal glucan synthase.
@en
Lipopeptide inhibitors of fungal glucan synthase.
@nl
type
label
Lipopeptide inhibitors of fungal glucan synthase.
@ast
Lipopeptide inhibitors of fungal glucan synthase.
@en
Lipopeptide inhibitors of fungal glucan synthase.
@nl
prefLabel
Lipopeptide inhibitors of fungal glucan synthase.
@ast
Lipopeptide inhibitors of fungal glucan synthase.
@en
Lipopeptide inhibitors of fungal glucan synthase.
@nl
P1476
Lipopeptide inhibitors of fungal glucan synthase.
@en
P2093
P577
1997-03-01T00:00:00Z